Programs
January 22, 2026
Istanbul
Build, Test & Scale What Matters: Inside the Bayer G4A Startup Acceleration Program
The Bayer G4A Startup Acceleration Program isn’t just about what you’re building. It’s equally about how far you can take it with the right support.
In its 9th Batch, the program—implemented in Türkiye together with Tenity—brings together startups working in Pharmaceuticals, Consumer Health, and Crop Science, and pairs them with hands-on mentorship, industry access, and concrete collaboration opportunities.

The Bayer G4A Startup Acceleration Program isn’t just about what you’re building. It’s equally about how far you can take it with the right support.

In its 9th Batch, the program—implemented in Türkiye together with Tenity—brings together startups working in Pharmaceuticals, Consumer Health, and Crop Science, and pairs them with hands-on mentorship, industry access, and concrete collaboration opportunities.

This is a program for startups that have moved beyond ideas and are now asking bigger questions: How do we validate faster? Who do we build with? How do we scale responsibly?

What Startups Gain from Bayer G4A

Before diving into the focus areas, here’s what founders consistently value most about the program:

  • 100 days of structured online training and mentorship focused on product, business model, and scale
  • Direct access to Bayer experts who work on real industry challenges every day
  • Opportunities to collaborate with Bayer teams, beyond theory and pitch decks
  • Exposure to Bayer’s global innovation ecosystem, opening doors beyond the program
  • Free software support packages to accelerate development
  • In addition, a grant of 500,000 TL will be awarded to each startup determined among the selected participants.

The goal is simple: help startups move faster, smarter, and with fewer blind spots.

Where Your Solution Fits

💊 Pharmaceuticals: Improving Care Across the Journey

In Pharmaceuticals, the program focuses on solutions that improve access to treatment, patient experience, and clinical efficiency—especially in Cardiology, Women’s Health, Ophthalmology, and Oncology.

Startups in this space often work on:

  • Patient and caregiver navigation
  • Treatment adherence and daily disease management
  • Early diagnosis and faster treatment access
  • Education and knowledge sharing for resident physicians

With Bayer’s domain expertise and mentor access, startups can test assumptions, refine use cases, and build solutions that fit real healthcare workflows.

🏥 Consumer Health: From Access to Actionable Insight

In Consumer Health, the emphasis is on digital access, smarter operations, and better engagement.

Relevant solutions include:

  • Next-generation digital sales channels and order management
  • Digital assistants supporting communication, promotion, and FAQs
  • Image and video-based shelf recognition and stock visibility
  • Tools that digitalize field processes and turn data into real-time insights

Startups benefit from working closely with experts who understand scale, regulation, and complex consumer ecosystems—helping transform promising tools into deployable solutions.

🌱 Crop Science: Turning Data into Decisions

Crop Science solutions in Bayer G4A focus on precision, efficiency, and data-driven agriculture.

This includes technologies that:

  • Enable variable-rate planting, spraying, and fertilization
  • Support smart machinery, mapping, and field optimization
  • Translate farm and field data into clear reports and actionable recommendations

With access to real industry perspectives, startups can sharpen their value proposition and ensure their technology delivers practical impact in the field.

Who Should Apply?

The Bayer G4A Startup Acceleration Program is built for startups that:

  • Are beyond the idea stage
  • Have a lean product, prototype, or early sales
  • Are building toward a scalable and sustainable business

Selected startups are evaluated by a jury of Bayer mentors, Bayer executives, and Tenity, and then join a program designed to combine industry insight, structured acceleration, and financial support.

Applications Are Open

Applications for the 9th Batch of the Bayer G4A Startup Acceleration Program are open until February 1, 2026.

If you’re building in Pharmaceuticals, Consumer Health, or Crop Science and want to strengthen your product with real industry collaboration—not just feedback—this program is built for you.